BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33651317)

  • 1. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy.
    Rossi RE; Milanetto AC; Andreasi V; Campana D; Coppa J; Nappo G; Rinzivillo M; Invernizzi P; Modica R; David A; Partelli S; Lamberti G; Mazzaferro V; Zerbi A; Panzuto F; Pasquali C; Falconi M; Massironi S;
    J Endocrinol Invest; 2021 Oct; 44(10):2227-2234. PubMed ID: 33651317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience.
    Massironi S; Campana D; Partelli S; Panzuto F; Rossi RE; Faggiano A; Brighi N; Falconi M; Rinzivillo M; Delle Fave G; Colao AM; Conte D
    Ann Surg Oncol; 2018 Oct; 25(11):3200-3206. PubMed ID: 30054824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
    Nießen A; Bergmann F; Hinz U; Schimmack S; Hackert T; Büchler MW; Strobel O
    Eur J Surg Oncol; 2020 Jun; 46(6):1088-1096. PubMed ID: 32088004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-functional duodenal neuroendocrine neoplasia in the proximal duodenum--case reports and proposal for a "high-risk-/low-risk-concept" in the decision for local endoscopic therapy].
    Scheerer F; Schmitt W
    Z Gastroenterol; 2013 Nov; 51(11):1240-50. PubMed ID: 24243571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 7. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
    Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
    World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
    Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
    Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
    World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms.
    Gay-Chevallier S; de Mestier L; Perinel J; Forestier J; Hervieu V; Ruszniewski P; Millot I; Valette PJ; Pioche M; Lombard-Bohas C; Subtil F; Adham M; Walter T
    Neuroendocrinology; 2021; 111(8):718-727. PubMed ID: 32335556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
    Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
    Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study.
    Mandair D; Kamieniarz L; Pizanias M; Weickert MO; Narayan A; O'Mahony LF; Caplin M; Ramage J; Prachalias A; Srirajaskanthan R; Toumpanakis C
    Sci Rep; 2022 Sep; 12(1):15762. PubMed ID: 36130981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
    Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
    Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The slow progressive nature of duodenal neuroendocrine tumor: a case report of long-term observation over 14 years.
    Takahashi K; Hatta W; Koike T; Kanno T; Ara N; Asanuma K; Asano N; Imatani A; Fujishima F; Sasano H; Shimosegawa T
    Clin J Gastroenterol; 2017 Oct; 10(5):469-473. PubMed ID: 28664383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?
    Massironi S; Rossi RE; Milanetto AC; Andreasi V; Campana D; Nappo G; Partelli S; Gallo C; Scaravaglio M; Zerbi A; Panzuto F; Pasquali C; Falconi M; Invernizzi P; On Behalf Of ItaNet Italian Association For Neuroendocrine Tumours Study Group
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
    Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
    Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
    Özaslan E; Demir S; Karaca H; Güven K
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.
    Zhang XF; Wu XN; Tsilimigras DI; Poultsides G; Rocha F; Abbott DE; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(8):1302-1310. PubMed ID: 31680243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.
    Clift AK; Faiz O; Al-Nahhas A; Bockisch A; Liedke MO; Schloericke E; Wasan H; Martin J; Ziprin P; Moorthy K; Frilling A
    J Gastrointest Surg; 2016 Jan; 20(1):180-8; discussion 188. PubMed ID: 26394880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.